BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12203763)

  • 1. Proton MRS in Kennedy disease: absolute metabolite and macromolecular concentrations.
    Mader I; Karitzky J; Klose U; Seeger U; Sperfeld A; Naegele T; Schick F; Ludolph A; Grodd W
    J Magn Reson Imaging; 2002 Aug; 16(2):160-7. PubMed ID: 12203763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
    Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in Kennedy disease.
    Lee CH; Lai PH; Liu CS; Li JY
    J Neurol Sci; 2009 Feb; 277(1-2):71-5. PubMed ID: 19019384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
    Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
    Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
    Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
    Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy.
    Riederer F; Bittsanský M; Schmidt C; Mlynárik V; Baumgartner C; Moser E; Serles W
    NMR Biomed; 2006 Aug; 19(5):544-53. PubMed ID: 16521092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder.
    Michael N; Erfurth A; Pfleiderer B
    Psychiatry Res; 2009 Apr; 172(1):78-81. PubMed ID: 19239983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla.
    Gruber S; Frey R; Mlynárik V; Stadlbauer A; Heiden A; Kasper S; Kemp GJ; Moser E
    Invest Radiol; 2003 Jul; 38(7):403-8. PubMed ID: 12821853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Horsman A
    Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study.
    Raininko R; Mattsson P
    Acta Radiol; 2010 Apr; 51(3):309-15. PubMed ID: 20170295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent anorexia nervosa: cross-sectional and follow-up frontal gray matter disturbances detected with proton magnetic resonance spectroscopy.
    Castro-Fornieles J; Bargalló N; Lázaro L; Andrés S; Falcon C; Plana MT; Junqué C
    J Psychiatr Res; 2007 Dec; 41(11):952-8. PubMed ID: 17112540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.